Skip to main content

Table 1 Baseline characteristic of patients

From: Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study

 

Overall

FMT

Placebo

P value

N

55

28

27

 

Age (mean ± SD)

40.3 ± 6.3

40.9 ± 7.4

39.7 ± 5.2

0.685

Weight (mean ± SD)

60.1 ± 3.9

59.2 ± 3.8

61.0 ± 4.0

0.833

Height (mean ± SD)

1.67 ± 0.07

1.69 ± 0.04

1.65 ± 3.98

0.734

BMI (mean ± SD)

21.7 ± 2.0

20.8 ± 1.6

22.5 ± 2.4

0.906

Male (%)

20(36.4)

10(35.7)

10(37.0)

0.906

Continue use of SIBO medication (%)

33(60.0)

17(60.7)

16(59.3)

0.579

Former tried SIBO medication (%)

42(76.4)

23(82.1)

19(70.4)

0.382

Former tried FODMAP diet (%)

26(47.3)

12(42.9)

14(51.9)

0.652

Born by casarean section (%)

7(12.7)

3(10.7)

4(14.8)

1

PPI (%)

9(16.4)

3(10.7)

6(22.2)

0.974

Antacid (%)

8(14.5)

4(14.3)

4(14.8)

0.523

Bile acid inhibitor (%)

5(9.1)

4(14.3)

1(3.7)

1

Immunosuppressor (%)

2(3.6)

1(3.6)

1(3.7)

1

  1. BMI, body mass index; SIBO, small intestinal bacterial overgrowth; PPI, proton pump inhibitor